Asthma trials recruiting in North Carolina

All Asthma trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
  NCT07532265 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Charlotte
• A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
  NCT06664619 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · North Carolina: Charlotte, High Point, Raleigh
• A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
  NCT07556159 · Phase: Not specified · Ages: 6 Years and older · Sex: All (male and female) · North Carolina: Asheville, Gastonia
• A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
  NCT07323654 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Chapel Hill, Durham
• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
  NCT07276724 · Phase: Phase 3 · Ages: 12 Years to 80 Years · Sex: All (male and female) · North Carolina: Gastonia, Winston-Salem
• A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
  NCT06023589 · Phase: Phase 3 · Ages: 5 Years to 11 Years · Sex: All (male and female) · North Carolina: Chapel Hill
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
  NCT06977581 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · North Carolina: Charlotte, Gastonia, Huntersville
• Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
  NCT06932263 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Asheville, Huntersville, Kings Mountain, Pinehurst
• Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma
  NCT07139899 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · North Carolina: Durham
• Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
  NCT06307665 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · North Carolina: Charlotte, Durham
• Individualizing Treatment for Asthma in Primary Care (Full Study)
  NCT07052942 · Phase: Phase 4 · Ages: 13 Years to 75 Years · Sex: All (male and female) · North Carolina: Chapel Hill, Charlotte
• Inspiratory Pulmonary Rehabilitation for Children With Obesity and Asthma
  NCT05608668 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years to 17 Years · Sex: All (male and female) · North Carolina: Durham
• Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
  NCT05945355 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years to 17 Years · Sex: All (male and female) · North Carolina: Durham
• NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)
  NCT02327897 · Phase: Not specified · Ages: 18 Years to 60 Years · Sex: All (male and female) · North Carolina: Research Triangle Park
• Personalized Environment and Genes Study
  NCT00341237 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female) · North Carolina: Chapel Hill, Research Triangle Park
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · North Carolina: Chapel Hill, Durham
• Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
  NCT07444567 · Phase: Phase 3 · Ages: 6 Years and older · Sex: All (male and female) · North Carolina: Durham
• Study of the Effect of Innate on the Inflammatory Response to Endotoxin
  NCT01143480 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · North Carolina: Research Triangle Park
• Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
  NCT03885245 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · North Carolina: Durham
• Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
  NCT07228026 · Phase: Not specified · Ages: 5 Years to 100 Years · Sex: All (male and female) · North Carolina: Asheville